Stempoint Capital Lp

Source: SEC Form 13F · as of Mar 2026

Stempoint Capital Lp holds 67 biotech & pharma companies tracked by BioSniper, totaling $987.1M in value as of Mar 2026 (SEC Form 13F).

Companies held

67

Total value held

$987.1M

CompanySharesValue
SRRKScholar Rock Holding Corp2,270,992$103.0M
ABVXAbivax SA627,582$69.9M
SNDXSyndax Pharmaceuticals Inc2,731,486$57.0M
RVMDREVOLUTION MEDICINES, INC.763,264$55.8M
IMVTImmunovant, Inc.1,692,988$37.6M
PRAXPraxis Precision Medicines, Inc.112,534$36.3M
MBXMBX Biosciences, Inc.998,938$29.8M
MLYSMineralys Therapeutics, Inc.1,066,756$28.9M
ELVNEnliven Therapeutics, Inc.726,876$28.5M
CGONCG Oncology, Inc.411,244$27.8M
BHVNBiohaven Ltd.3,188,982$27.0M
ROIVRoivant Sciences Ltd.771,600$21.4M
ARQTArcutis Biotherapeutics, Inc.827,584$19.5M
GPCRStructure Therapeutics Inc.400,534$19.3M
SRZNSurrozen Inc.721,620$19.2M
AMLXAmylyx Pharmaceuticals, Inc.1,339,370$18.6M
DYNDyne Therapeutics, Inc.1,012,150$18.4M
EWTXEdgewise Therapeutics, Inc.581,728$18.3M
CYTKCYTOKINETICS INC259,154$17.1M
SYRESpyre Therapeutics, Inc.335,212$16.9M
DNLIDenali Therapeutics Inc.853,122$16.4M
XENEXenon Pharmaceuticals Inc.281,510$16.4M
CLDXCelldex Therapeutics, Inc.508,534$16.1M
TYRATyra Biosciences, Inc.586,354$15.4M
PTGXProtagonist Therapeutics, Inc145,154$15.3M
DNTHDianthus Therapeutics, Inc. /DE/171,004$14.4M
DFTXDefinium Therapeutics Inc.650,966$12.3M
BIOABioAge Labs, Inc.677,308$11.8M
NAMSNEWAMSTERDAM PHARMA CO N.V.361,316$11.6M
ACADACADIA PHARMACEUTICALS INC485,132$10.8M
ASMBASSEMBLY BIOSCIENCES, INC.370,870$10.3M
ALMSALUMIS INC.459,132$10.1M
NRIXNurix Therapeutics, Inc.630,452$9.8M
ZURAZura Bio Ltd1,507,040$9.0M
EVMNEvommune, Inc.387,554$8.8M
TNGXTango Therapeutics, Inc.401,838$8.4M
SNSESensei Biotherapeutics, Inc.265,746$8.4M
RLMDRELMADA THERAPEUTICS, INC.1,194,818$8.3M
ERASErasca, Inc.479,722$7.8M
JNJJOHNSON & JOHNSON30,830$7.5M
XFORX4 Pharmaceuticals, Inc1,701,484$7.0M
PCVXVaxcyte, Inc.118,122$6.9M
WHWKWhitehawk Therapeutics, Inc.1,878,738$6.5M
ALKSAlkermes plc.160,984$5.7M
PHVSPharvaris N.V.173,274$4.9M
IVVDInvivyd, Inc.3,749,092$4.9M
JBIOJade Biosciences, Inc.308,068$4.3M
TWSTTwist Bioscience Corp86,220$4.1M
MPLTMapLight Therapeutics, Inc.200,000$4.1M
AVTXAvalo Therapeutics, Inc.269,484$4.0M
IONSIONIS PHARMACEUTICALS INC52,770$4.0M
IMCRImmunocore Holdings plc127,086$3.8M
FBRXForte Biosciences, Inc.116,040$3.0M
SIONSionna Therapeutics, Inc.73,080$2.9M
SABSSAB BIOTHERAPEUTICS, INC.750,000$2.9M
SLDBSolid Biosciences Inc.390,806$2.8M
LPCNLipocine Inc.320,840$2.6M
QUREuniQure N.V.156,132$2.6M
LBRXLB PHARMACEUTICALS INC100,000$2.5M
CCCCC4 Therapeutics, Inc.906,472$2.4M
CAPRCAPRICOR THERAPEUTICS, INC.75,184$2.3M
BDSXBiodesix Inc.140,008$2.0M
STROSUTRO BIOPHARMA, INC.46,590$1.2M
SPRBSPRUCE BIOSCIENCES, INC.12,720$831K
VTGNVistagen Therapeutics, Inc.1,233,498$116K
TERNTerns Pharmaceuticals, Inc.200,000$15K
OLMAOlema Pharmaceuticals, Inc.50,000$8K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Stempoint Capital Lp — Biotech 13F Holdings & Portfolio | BioSniper